2014
DOI: 10.3390/md12095055
|View full text |Cite
|
Sign up to set email alerts
|

Chronic Toxicity Study of Neosaxitoxin in Rats

Abstract: Neosaxitoxin (NeoSTX) is a specific reversible blocker of voltage gated sodium channels on excitable cells. In the last decade, it has been tested in a number of interesting clinical trials, however there is still little information available on mammalian toxicity. Rats were treated for 12 weeks with doses of 1, 3 or 6 μg/kg of subcutaneous NeoSTX. At weeks 12 and 17, animals were sacrificed and blood samples collected for hematological and biochemical analysis. Organs were harvested for weight determination a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 36 publications
0
11
0
Order By: Relevance
“…The kidneys and livers were immediately stored in 10% paraffin for histology. Paraffin sections were made and stained with hematoxylin and eosin for a thorough histopathological study [ 17 , 18 ]. Hematological analysis of the blood samples was performed using an automatic hematology analyzer.…”
Section: Methodsmentioning
confidence: 99%
“…The kidneys and livers were immediately stored in 10% paraffin for histology. Paraffin sections were made and stained with hematoxylin and eosin for a thorough histopathological study [ 17 , 18 ]. Hematological analysis of the blood samples was performed using an automatic hematology analyzer.…”
Section: Methodsmentioning
confidence: 99%
“…Repeated exposure of rats to subacute doses of neoSTX for 12 weeks (6 µg/kg, once daily, subcutaneous) caused a reduction of body weight and food intake during the treatment period and the animals recovered quickly after the treatment was interrupted. No other behavioral changes were observed and no damage to several organs was detected by histological evaluation [ 16 ]. However, serum bilirubin, γ-glutamyltransferase (GGT) and aspartate aminotransferase (AST, formerly SGOT), three markers of liver damage, were elevated after 12 weeks of neoSTX treatment.…”
Section: Saxitoxinsmentioning
confidence: 99%
“…However, serum bilirubin, γ-glutamyltransferase (GGT) and aspartate aminotransferase (AST, formerly SGOT), three markers of liver damage, were elevated after 12 weeks of neoSTX treatment. These changes might reflect the detoxifying effort or be a consequence of the food intake reduction [ 16 ]. Lower doses (half and 1/6) had no effect at all.…”
Section: Saxitoxinsmentioning
confidence: 99%
“…No data on the short and long term repeated toxic effects of STX-group toxins in animals or humans were available in 2009 for the EFSA scientific opinion; a similar data gap could be highlighted at present, except for a paper from Zepeda et al (2014) which investigated the acute and chronic toxicity of NeoSTX by different routes of administration, showing that only the highest dose studied (6 µg NeoSTX/kg bw) when administered subcutaneously (not relevant for the dietary exposure) induced a reduction of weight and food consumption accompanied by a cholestasic pattern at the end of the treatment period. The effects were completely normalized with the drug withdrawal.…”
Section: Acute Toxicitymentioning
confidence: 99%